Vaccination with Recombinant Modified Myostatin Induces an Autoimmune Response to Myostatin in Calves
https://doi.org/10.33647/2074-5982-21-4-54-58
Abstract
The search for ways to increase the meat productivity of agricultural animals is an important direction in the field of immunobiotechnology. Immunization of sheep with recombinant myostatin (rMST) led to the development of an antibody response correlating with animal weight gain. The possibility of enhancing the immunogenicity of a recombinant analogue of endogenous mature myostatin for the purpose of vaccination of young cattle was considered. A genetic construct was created for the expression of recombinant modified myostatin (rmMST), in which cysteine was replaced by serine, and the producer strain E. coli BL21(DE3)/pET-mMSTN was obtained, expressing the recombinant protein with high efficiency. Calves were immunized with rMST and rmMST twice with an interval of 30 days. Using the ELISA test system, a higher immunogenicity of rmMST was shown.
About the Authors
E. M. KoloskovaRussian Federation
Elena M. Koloskova, Cand. Sci. (Biol.)
249013, Kaluga Region, Borovsk, Institute VillageV. A. Ezerskiy
Russian Federation
Vadim A. Ezerskiy
249013, Kaluga Region, Borovsk, Institute VillageK. S. Ostrenko
Russian Federation
Konstantin S. Ostrenko, Dr. Sci. (Biol.)
249013, Kaluga Region, Borovsk, Institute VillageN. V. Belova
Russian Federation
Nadezhda V. Belova, Cand. Sci. (Biol.)
249013, Kaluga Region, Borovsk, Institute VillageReferences
1. Ezerskij V.A., Koloskova E.M. Zavisimost' antitel'nogo otveta molodnyaka ovec ot sposoba immunizacii rekombinantnym miostatinom [Dependence of the antibody response of young sheep on the method of immunization with recombinan tmyostatin]. Biomeditsina [Journal Biomed]. 2024;20(3Е):42–48. (In Russian)]. DOI: 10.33647/27130428-20-3E-42-48.
2. Koloskova E.M., Ezerskiy V.A., Zhukova O.B. Poluchenie bakterial'nogo rekombinantnogo miostatina dlya indutsirovaniya sinteza spetsificheskikh k miostatinu autoantitel [Preparation of bacterial recombinant myostatin to induce the synthesis of myostatin-specific autoantibodies]. Biomeditsina [Journal Biomed]. 2022;18(3):22–26. (In Russian)]. DOI: 10.33647/2074-5982-18-3-22-26.
3. Koloskova E.M., Ezerskij V.A., Zhukova O.B. Poluchenie rekombinantnogo modificirovannogo miostatina s povyshennoj immunogennost'yu [Production of recombinant modified myostatin with increased immunogenicity]. Problemy biologii produktivnyh zhivotnyh [Biology Problems of Productive Animal]. 2024;4:19–28. (In Russian)].
4. Chen M.M., Zhao Y.P., Zhao Y., Deng S.L., Yu K. Regulation of myostatin on the growth and development of skeletal muscle. Front. Cell Dev. Biol. 2021;9:785712. DOI: 10.3389/fcell.2021.785712.
5. Jackson M.F., Luong D., Vang D.D., Garikipati D.K., Stanton J.B., Nelson O.L., Rodgers B.D. The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism. The Journal of Endocrinology. 2012;213(3):263–275.
6. Nielsen T.L., Vissing J., Krag T.O. Antimyostatin treatment in health and disease: The story of great expectations and limited success. Cells. 2021;10(3):533. DOI: 10.3390/cells10030533.
7. Saetang J., Roongsawang N., Sangkhathat S., Voravuthikunchai S.P., Sangkaew N., Prompat N., Srichana T., Tipmanee V. Surface cysteine to serine substitutions in IL-18 reduce aggregation and enhance activity. PeerJ. 2022;10:e13626. DOI: 10.7717/peerj.13626.
8. Xu Y., Mao L., Zheng Y. Prokaryotic expression and immunogenicity analysis of yak recombinant myostatin. Anim. Biotechnol. 2012;23(4):253–260. DOI: 10.1080/10495398.2012.722157.
Review
For citations:
Koloskova E.M., Ezerskiy V.A., Ostrenko K.S., Belova N.V. Vaccination with Recombinant Modified Myostatin Induces an Autoimmune Response to Myostatin in Calves. Journal Biomed. 2025;21(4):54-58. (In Russ.) https://doi.org/10.33647/2074-5982-21-4-54-58



























